Dr Lipid
drlipid.bsky.social
Dr Lipid
@drlipid.bsky.social
Longtime Lipid/Lipoprotein Educator with an extensive resume including Associate Editor of Journal of Clinical Lipidology. Practiced in NJ for 37 years. Has done 4000 lectures in all 50 states & authored many publications. Has two major awards from NLA
An alert and invitation to join me and my tag-team partner Dr Kellyann Niotis in a live virtual "fireside chat" with @jfwellness1 called Protecting Your Brain & Heart in Midlife & Beyond - Register at us06web.zoom.us/webinar/regi...
Welcome! You are invited to join a webinar: Protecting Your Brain & Heart in Midlife & Beyond. After registering, you will receive a confirmation email about joining the webinar.
Join us for a powerful conversation with Coach Jill Foos, and two leading experts—Dr. Kellyann Niotis, the first fellowship-trained preventive neurologist, and Dr. Thomas Dayspring, internationally re...
us06web.zoom.us
November 3, 2025 at 6:23 PM
LabCorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older. www.fiercebiotech.com/medtech/labc...
Labcorp signs on to carry Roche's newly FDA-cleared Alzheimer's blood test
Labcorp pla | Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older.
www.fiercebiotech.com
October 29, 2025 at 6:09 PM
For those of you who missed @PeterAttiaMD on 60 minutes last night - enjoy Dr. Attia Will See You Now | Sunday at www.youtube.com/watch?v=li4jARm9t40 @nationallipid.bsky.social @aspcardio.bsky.social
Dr. Attia Will See You Now | Sunday on 60 Minutes
YouTube video by 60 Minutes
www.youtube.com
October 27, 2025 at 7:20 PM
Large study investigated different classes of BP drugs & the risk of incident dementia. Conclusion: physicians & patients should consider the reduced risk of all-cause dementia and Vascular Dementia with ARB compared with ACE-I in their risk–benefit assessment. academic.oup.com/ageing/artic...
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study
AbstractBackground. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-II receptor blockers (ARBs) are first-line antihypertensive drugs for
academic.oup.com
October 20, 2025 at 1:58 PM
Want to listen to the one and only fellowship trained preventive Neurologist? Podcast is "Brain Health & Preventative Neurology" with Dr. Kellyann Niotis - Who will also be speaking
@nationallipid.bsky.social meeting on Saturday. open.spotify.com/episode/4fpt...
319: Brain Health & Preventative Neurology with Dr. Kellyann Niotis
open.spotify.com
October 16, 2025 at 1:44 PM
Want to know where Lipidology is going and some of the new drugs? Check out this open access chat by two giants in the field entitled "Pharmacotherapy Development and Trends in Lipidology: An Expert Discussion" www.lipidjournal.com/article/S1933-2874(25)00423-4/fulltext @nationallipid.bsky.social
Pharmacotherapy Development and Trends in Lipidology: An Expert Discussion
Cardiovascular diseases are leading causes of morbidity and mortality in the United States and globally. Atherosclerotic cardiovascular diseases (ASCVD), such as coronary heart disease and cerebrovasc...
www.lipidjournal.com
October 10, 2025 at 3:04 PM
Many thanks to FUNDACION CARDIOINFANTIL of Bogota Columbia, for the invitation and high honor to lecture virtually at their Cardiovascular Congress today on the topic of Lipid and Lipoprotein complexities. It was a pleasure to join with my long-time Argentinian colleague & Lipidologist Pablo Coral
October 3, 2025 at 12:21 AM
What is the size of the thrombus in a coronary artery that can send one to Heaven or the CCU? Coronary artery lumens are quite small, and a cholesterol-rich plaque rupture or erosion will induce a thrombus. A tiny thrombus will partially block (cause ischemia) or totally block (cause infarction).
September 21, 2025 at 12:32 PM
On this podcast, I along with an oncologist (speaking about cancer) and I on lipids had the opportunity to educate a very different crowd - the Finance World - I was a guest on Jimmie Lee's The Bull of Wall Street Podcast - My section starts at 21:23 - Enjoy www.youtube.com/watch?v=FPSE...
September 19, 2025 at 11:17 PM
To further confuse the EPA vs EPA+DHA story. Here is new data from STRENGTH showing EPA + DHA reduced MACE in Asian patients. Authors had no reasons but perhaps due to Asian incidence of IR and TG issues. www.atherosclerosis-journal.com/article/S002...
September 17, 2025 at 4:50 PM
DHA is crucial for maintaining brain neuron integrity and may inhibit tau phosphorylation. High doses (0.9–1.8 g/d) of DHA/EPA have shown improvements in cognitive function, while low doses (0.3–0.7 g/d) did not. www.sciencedirect.com/science/article/pii/S0002916523463204?via%3Dihub
September 16, 2025 at 4:01 PM
Learn why specific sterol measurements are tools to evaluate cholesterol synthesis/absorption - then entertain - an at this time a hypothesis why some degree of reducing brain cholesterol synthesis will likely reduce dementia (in those prone to it) pharmacypodcastnetwork.podbean.com/e/desmostero...
Desmosterol, Statins, and Cognition | Geriatric Pharmacy Focus | Pharmacy Podcast Network
This is a fascinating podcast episode from Dr. Lipid himself on desmosterol.  What is it?  How do we measure it?  Why should we care?Pharmacists are well-positioned to guide patients in understanding ...
pharmacypodcastnetwork.podbean.com
September 10, 2025 at 11:35 AM
What's a better way to kill an hour+ other that viewing @theproof with Simon Hill interviewing Daniel Soffer and Thomas Dayspring, MD FACP, FNLA reviewing Lipid-modulating medications - theproof.com/lowering-cho... @aspcardio.bsky.social @nationallipid.bsky.social @familyheartfdn.bsky.social
Lowering cholesterol with medicine | Dr Thomas Dayspring and Dr Dan Soffer
In this episode of The Proof, I’m joined once again by two of the world’s leading lipid experts, Dr Tom Dayspring and Dr Dan Soffer. Together we take a deep dive into the world of lipid-lowering thera...
theproof.com
September 2, 2025 at 5:35 PM
"Understanding the Lipid Panel" - next are insights on Non-HDL-C which refers (1) to the mass (weight) in mg of cholesterol within all of the apoB-containing lipoproteins per dL or (2) the number (in mmols) of cholesterol molecules in all the apoB-particles per L.
September 1, 2025 at 11:54 PM
Part 2 of my discussion with @_CynthiaThurlow on her Everyday Wellness Podcast where we continue the journey into lipid/lipoprotein issues with an emphasis on women www.youtube.com/watch?v=IoKZvN8BWbg&t=139s @aspcardio.bsky.social @familyheartfdn.bsky.social @nationallipid.bsky.social
August 27, 2025 at 4:18 PM
Periodically I repost this very useful document (glossary of terms) for those try to master lipids/lipoproteins. Print it out - peterattiamd.com/glossary-lip... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social @escardio.bsky.social
Narrative glossary: lipids - Peter Attia
A companion post for the podcast episodes with Thomas Dayspring, M.D., FACP, FNLA (October 15-19, 2018).
peterattiamd.com
August 23, 2025 at 1:03 PM
Introducing Vishnu Priya Pulipati, MD, FACE, who is an internist/endocrinologist/lipidologist who also did a preventive cardiology fellowship & now practices in Tulsa, OK. Check out her podcast to help clinicians better understand lipids. Please provide feedback to her. lipidcurious.com
LipidCurious
LipidCurious is a podcast for clinicians who want practical, evidence-based clarity in lipid management
lipidcurious.com
August 22, 2025 at 11:47 PM